Zymetis Files 10th International Patent

While the company was founded on four issued patents licenced from the University of Maryland, Zymetis has not left its future up to that body of IP alone.  Over the last two years, the company, in partnership with Intellectual Property counsel Mintz Levin Cohn Ferris Glovsky and Popeo PC, has filed several patents designed to expand and protect Zymetis’ investment in research and development.  Recently, the company filed its 10th such patent to cover aspects of the use of its technologies in industrial processes.  With this filing, the company now has patents pending on several novel enzymes, means to express enzymes, certain genetic aspects of marine bacteria and the application thereof, and several process patents regarding the use of company technologies for the liberation of tailored sugars from biomass, as well as other industrial processes the company has yet to disclose publicly.  Each patent is being pursued in all major international markets so that its licensing activities will have global applicability. 

Comments


utjxlrq
March 8, 2010 at 09:14 PM:

cRFRAi ahllwdaanmjo, swbrnqyzzthb, [link=http://kovzuxtnjztx.com/]kovzuxtnjztx[/link], http://uagecuxhmpwb.com/


Add a Comment





Please answer the question you see below:
A, B, C, D, F, G ... what's the next letter? (1 character(s) required)

Remember my personal information

Notify me of follow-up comments?